Back
Vertex Pharmaceuticals
VRTX
$508.00
-1.62%
Overview
Vertex Pharmaceuticals Incorporated is a biotechnology company. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing...
Open
$0.00
Prior close
$516.34
Today's high
$0.00
Today's low
$0.00
52 Week high
$560.25
52 Week low
$374.17
News
Zacks Investment Research • 12 hours ago • VRTX
Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
Seeking Alpha • 4 days ago • VRTX
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
MarketBeat • 4 days ago • VRTX
Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts Ahead
MarketBeat • 7 days ago • VRTX
Vertex Pharmaceuticals Highlights Catalyst-Rich Pipeline Beyond Cystic Fibrosis
MarketBeat • 7 days ago • VRTX
Vertex Pharmaceuticals Maps Growth Beyond CF at Cantor Conference
